Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis

Chen Xiao-yin; Li En-qing; Yang Qin-he; Zhang Qun; Sun Li; Xu Yun-sheng; Shen Qiang

doi:10.1007/BF02836567

Your Location：

Home >

Browse articles >

Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis

OriginalPaper | Updated：2021-08-27

- Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis
- Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis
- 中国结合医学杂志（英文版） 2004年10卷第1期页码：63-65
- Affiliations：
  
  1. Department of TCM, Medical College, Jinan University,Guangzhou
  2. College of Life Science and Tech-nology, Jinan University,Guangzhou
  3. The Fourth Department of the First Affiliated Hospital, Guangzhou University of TCM,China
- Author bio：
- Funds：
  
  The study is funded by Guangdong Provincial Administration of TCM (No. 102048)
- DOI：10.1007/BF02836567
  中图分类号：
- 纸质出版日期：2004，
Scan for full text
Xiao-yin, C., En-qing, L., Qin-he, Y. et al. Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis., Chin. J. Integr. Med. 10, 63–65 (2004). https://doi.org/10.1007/BF02836567

Chen Xiao-yin, Li En-qing, Yang Qin-he, et al. Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis[J]. Chinese Journal of Integrative Medicine, 2004,10(1):63-65.
Xiao-yin, C., En-qing, L., Qin-he, Y. et al. Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis., Chin. J. Integr. Med. 10, 63–65 (2004). https://doi.org/10.1007/BF02836567 DOI：

Chen Xiao-yin, Li En-qing, Yang Qin-he, et al. Clinical study of Dahuang Zhechong pill in treating posthepatitis B hepatic fibrosis[J]. Chinese Journal of Integrative Medicine, 2004,10(1):63-65. DOI： 10.1007/BF02836567.

摘要

Abstract

关键词

hyaluronic acidHepatic FibrosisApricot KernelChronic Hepatic DiseaseWestern Medicine Group

Keywords

hyaluronic acidHepatic FibrosisApricot KernelChronic Hepatic DiseaseWestern Medicine Group

references

Zeng MD. The strategy for the treatment of hepatic fibrosis. Chin J Hepatol 2001;9(2): 68–69.

Wang BE. Treatment of hepatic fibrosis with traditional Chinese medicine. Chin J Hepatol 2001;9(2): 120–121.

Prevention and treatment program for virus hepatitis (Provisional). Chin J Infect Dis 1995; 13(4): 241.

Ninomiya T, Yoon S, Hayashi Y, et al. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-α; histological evaluation by a modified histological activity index scoring system. J Gastroenterol 1998;13(1): 68.

Bcher Wo, Dekel B, Schwerin W, et al. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte response by therapeutic vaccination in the trimera mouse model of chronic HBV infection. Eur J Immunol 2001;21: 2071–2079.

Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the knodell histology activity index and beyond. Hepatology 2000; 31: 241–246.

Gan LW, Wang GJ, Li YL, et. al. Effect of Kushengjian on liver fibrosis in rats. Acad J Second Milit Med Univ 1999;20 (3): 445–448.

FULL TEXT LINK

More>

浏览量

378

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effects of Ganfukang (肝复康) on expression of connective tissue growth factor and focal adhesion kinase/protein kinase B signal pathway in hepatic fibrosis rats

Clinical observation of the effect of Xuesaitong soft capsule on post-hepatitis fibrosis

Integrative Chinese and western medicine approach In treating 64 patients with anovular infertility

Relationship between liver fibrosis criteria and syndrome-type of TCM in patients with non-alcoholic fatty liver